Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Adrian Buckner

Psychiatry Bristol, TN Medical Doctor

NPI 1437169901 CMS profile 246009

1 Medical Park Blvd, Bristol, TN 37620

Open in the dashboard

General payments

$64,211

650 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Adrian Buckner of Bristol, TN is reported in the CMS Open Payments database as having received $64,211 across 650 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $4,954 87
2021 General $20,177 152
2020 General $12,208 156
2019 General $26,872 255

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adrian Buckner
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Adrian Buckner were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Adrian Buckner Psychiatry median Middle half National median
2019 $26,872 $184 $59–$605 $163
2020 $12,208 $119 $36–$372 $114
2021 $20,177 $143 $43–$576 $132
2022 $4,954 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Otsuka America Pharmaceutical, Inc. $26,754 113 payments
  2. Allergan Inc. $12,314 66 payments
  3. Alkermes, Inc. $9,698 51 payments
  4. Teva Pharmaceuticals USA, Inc. $4,880 60 payments
  5. Janssen Pharmaceuticals, Inc $4,000 52 payments
  6. AbbVie, Inc. $2,124 32 payments
  7. Sunovion Pharmaceuticals Inc. $1,177 93 payments
  8. Lundbeck LLC $902 59 payments
  9. Bausch Health US, LLC $605 34 payments
  10. Neurocrine Biosciences, Inc. $511 23 payments
  11. Other $1,246 67 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,596 35 payments
  2. Food and Beverage $9,632 588 payments
  3. Travel and Lodging $3,824 22 payments
  4. Consulting Fee $888 1 payment
  5. Education $272 4 payments
Products named General payments · program years 2019–2022
  1. ABILIFY MAINTENA $26,677 101 payments
  2. VRAYLAR Neuroscience $12,314 66 payments
  3. LYBALVI Cns $8,293 20 payments
  4. LYBALVI Cns $8,293 20 payments
  5. LYBALVI Cns $8,117 8 payments
  6. LYBALVI Cns $8,117 8 payments
  7. AUSTEDO $4,638 57 payments
  8. SPRAVATO $3,358 6 payments
  9. REXULTI $2,190 67 payments
  10. VRAYLAR Neuroscience $2,124 32 payments
  11. Other $12,310 498 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

650 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record